• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Cell Rep Med . Oral SARS-CoV-2 inoculation establishes subclinical respiratory infection with virus shedding in golden Syrian hamsters

tetano

Editor, Senior Moderator
Cell Rep Med


. 2020 Sep 22;100121.
doi: 10.1016/j.xcrm.2020.100121. Online ahead of print.
Oral SARS-CoV-2 inoculation establishes subclinical respiratory infection with virus shedding in golden Syrian hamsters


Andrew Chak-Yiu Lee[SUP] 1 [/SUP], Anna Jinxia Zhang[SUP] 1 [/SUP], Jasper Fuk-Woo Chan[SUP] 1 2 [/SUP], Can Li[SUP] 1 [/SUP], Zhimeng Fan[SUP] 1 [/SUP], Feifei Liu[SUP] 1 [/SUP], Yanxia Chen[SUP] 1 [/SUP], Ronghui Liang[SUP] 1 [/SUP], Siddharth Sridhar[SUP] 1 2 [/SUP], Jian-Piao Cai[SUP] 1 [/SUP], Vincent Kwok-Man Poon[SUP] 1 [/SUP], Chris Chung-Sing Chan[SUP] 1 [/SUP], Kelvin Kai-Wang To[SUP] 1 2 [/SUP], Shuofeng Yuan[SUP] 1 [/SUP], Jie Zhou[SUP] 1 [/SUP], Hin Chu[SUP] 1 [/SUP], Kwok-Yung Yuen[SUP] 1 2 [/SUP]



Affiliations

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is transmitted largely by respiratory droplets or airborne aerosols. Despite being frequently found in the immediate environment and faeces of patients, evidence supporting oral acquisition of SARS-CoV-2 is unavailable. Utilizing Syrian hamster model, we demonstrate that the severity of pneumonia induced by intranasal inhalation of SARS-CoV-2 increases with virus inoculum. SARS-CoV-2 retains its infectivity in vitro in simulated human fed-gastric and fasted-intestinal fluid after two hours. Oral inoculation with the highest intranasal inoculum(10[SUP]5[/SUP]PFU) causes mild pneumonia in 67% (4/6) of the animals with no weight loss. The lung histopathology score and viral load are significantly lower than those infected by the lowest intranasal inoculum(100PFU). However, 83% oral infection (10/12 hamsters) have similar level of detectable viral shedding from oral swabs and faeces as that of intranasally infected hamsters. Our findings indicate oral acquisition of SARS-CoV-2 can establish subclinical respiratory infection with less efficiency.

Keywords: COVID-19; SARS-CoV-2; coronavirus; gastrointestinal; hamster; oral; subclinical.
 
Back
Top Bottom